In this study, we collected relevant data of carboplatin-treated ovarian cancer patients, such as age and disease type, and detected the related CX3CL1/CX3CR1 SNPs by Sequenom Mass ARRAY technology (based on the Sequenom platform) to evaluate whether they are efficacy-related alleles, determine the correlation between the above indicators and clinical efficacy, and provide a basis for the individualization of ovarian cancer. The gene discussed is CX3CL1; the disease is ovarian carcinoma.